Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.

Annals of the New York Academy of Sciences - 26 Sept 1997

Schneider L S, Farlow M

Abstract excerpt

In light of evidence that estrogen replacement might affect cholinergic function, we examined possible effects of estrogen replacement therapy (ERT) on clinical response to the cholinesterase inhibitor tacrine in women with Alzheimer's disease (AD). In a previously reported 30-week, randomized, double-blind, placebo-controlled, multicenter clinical trial, 14.5% of 318 women with evaluable data had been receiving...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Choline O-Acetyltransferase

Share to Double-Blind Method

Share to Drug Therapy, Combination

Share to APOE gene

Share to Genotype

Source

Identifiers

PMID: 9329702
DOI: 10.1111/j.1749-6632.1997.tb48482.x

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.PMID 9329702Read ↗

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.Semantic proximity Read ↗

Apolipoprotein E genotype and gender influence response to tacrine therapy.Semantic proximity Read ↗

Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.Semantic proximity Read ↗

Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.Semantic proximity Read ↗

Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.Semantic proximity Read ↗

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.Semantic proximity Read ↗

Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.Semantic proximity Read ↗

Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.Semantic proximity Read ↗

Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.Semantic proximity Read ↗

Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-world DataSemantic proximity Read ↗

Cognitive function in nondemented older women who took estrogen after menopause.Semantic proximity Read ↗

Estrogen use and early onset Alzheimer's disease: a population-based study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.